216 related articles for article (PubMed ID: 27695057)
1. The Expression and Prognostic Roles of MCMs in Pancreatic Cancer.
Peng YP; Zhu Y; Yin LD; Zhang JJ; Guo S; Fu Y; Miao Y; Wei JS
PLoS One; 2016; 11(10):e0164150. PubMed ID: 27695057
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
3. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
[TBL] [Abstract][Full Text] [Related]
4. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Analysis of the Expression and Prognosis for MCMs in Human Gastric Cancer.
Guo F; Kong WN; Feng YC; Lv J; Zhao G; Wu HL; Ai L; Zhou X; Cai XL; Sun W; Ma XM
Technol Cancer Res Treat; 2020; 19():1533033820970688. PubMed ID: 33167799
[TBL] [Abstract][Full Text] [Related]
6. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
[TBL] [Abstract][Full Text] [Related]
7. Genome-wide investigation of the clinical significance and prospective molecular mechanism of minichromosome maintenance protein family genes in patients with Lung Adenocarcinoma.
Liu K; Kang M; Liao X; Wang R
PLoS One; 2019; 14(7):e0219467. PubMed ID: 31323040
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer.
Guo JC; Li J; Zhao YP; Zhou L; Cui QC; Zhou WX; Zhang TP; You L
PLoS One; 2015; 10(3):e0120332. PubMed ID: 25789763
[TBL] [Abstract][Full Text] [Related]
9. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance.
Zhou L; Wang MY; Liang ZY; Zhou WX; You L; Pan BJ; Liao Q; Zhao YP
Hum Pathol; 2016 Oct; 56():171-7. PubMed ID: 27346572
[TBL] [Abstract][Full Text] [Related]
10. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
[No Abstract] [Full Text] [Related]
11. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma.
Cheng Y; Wang K; Geng L; Sun J; Xu W; Liu D; Gong S; Zhu Y
EBioMedicine; 2019 Feb; 40():382-393. PubMed ID: 30639415
[TBL] [Abstract][Full Text] [Related]
12. Multiomics profiling of the expression and prognosis of MCMs in endometrial carcinoma.
Lan H; Yuan J; Chen X; Liu C; Guo X; Wang X; Song J; Cao K; Xiao S
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34859821
[TBL] [Abstract][Full Text] [Related]
13. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 in pancreatic cancer and its significance.
Li XP; Zhang XW; Zheng LZ; Guo WJ
Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
16. MCM family in gastrointestinal cancer and other malignancies: From functional characterization to clinical implication.
Wang Y; Chen H; Zhang J; Cheng ASL; Yu J; To KF; Kang W
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188415. PubMed ID: 32822825
[TBL] [Abstract][Full Text] [Related]
17. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
18. MCM2 expression levels predict diagnosis and prognosis in gastric cardiac cancer.
Liu M; Li JS; Tian DP; Huang B; Rosqvist S; Su M
Histol Histopathol; 2013 Apr; 28(4):481-92. PubMed ID: 23329420
[TBL] [Abstract][Full Text] [Related]
19. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
[TBL] [Abstract][Full Text] [Related]
20. Locally advanced pancreatic cancer: association between prolonged preoperative treatment and lymph-node negativity and overall survival.
Kadera BE; Sunjaya DB; Isacoff WH; Li L; Hines OJ; Tomlinson JS; Dawson DW; Rochefort MM; Donald GW; Clerkin BM; Reber HA; Donahue TR
JAMA Surg; 2014 Feb; 149(2):145-53. PubMed ID: 24306217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
